Ginseng Lowers Fatigue in Cancer Study
A multicenter study included several hundred cancer survivors on ginseng or placebo for eight weeks.
A phase III study on ginseng and cancer patients suggests that American ginseng (Panax quinquefolius) can combat cancer-related fatigue.
In a study involving 40 universities, researchers assigned 364 fatigued cancer survivors to 2 g of ginseng or placebo daily for eight weeks. At baseline, four weeks, and eight weeks, subjects were evaluated for fatigue scores, measured using the Multidimensional Fatigue Symptom Inventory–Short Form. Many subjects dropped out of the study before its completion-80, according to Reuters-but that would still leave 284 subjects.
At eight weeks, ginseng users displayed significantly lower fatigue scores compared placebo users, and with no significant difference in adverse event reports (many of which are cancer treatment-related symptoms, such as nausea and vomiting). Benefits of ginseng appeared greater in subjects undergoing active cancer treatment.
The phase III study on ginseng and cancer patients, published in the Journal of the National Cancer Institute, complements much previous research on ginseng and fatigue in various populations. In 2013 alone, at least two other studies have looked at ginseng and fatigue-both with positive results.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
